SUBSCRIBE
SUBSCRIBE

Australia

Biotech Bay
Party Like It’s 1999
April 1, 2008
 · 
1 min read
Biotech Bay
Dinosaurs and Drug Companies
April 1, 2008
 · 
2 min read
Biotech Bay
Desperate But Not Crazy
April 1, 2008
 · 
2 min read
Biotech Bay
Keeping Your Hands Clean
March 31, 2008
 · 
3 min read
Biotech Bay
Biogenerics in ’08?
March 31, 2008
 · 
2 min read
Biotech Bay
Time to Buy Biotech?
March 31, 2008
 · 
3 min read
Biotech Bay
Targeting Aggressive Breast Cancers By Putting Them To Sleep, Garvan Institute of Medical Research and University of California, San Francisco (UCSF) Study
March 26, 2008
 · 
1 min read
Drug Development
Roche Holding AG’s Xenical Helps Lower Blood Pressure, Abbott Laboratories’ Appetite Suppressant Meridia Did Not
March 25, 2008
 · 
1 min read
Drug Development
Body Building Pill May Prevent Baby Brain Damage, Monash University Study
March 12, 2008
 · 
1 min read
Genetic Analysis Reveals Range Of Rett Syndrome, Telethon Institute for Child Health Research
March 11, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
ACCENT DATA PRESENTED AT 2026 ASCO GASTROINTESTINAL CANCER SYMPOSIUM
January 13, 2026
 · 
3 min read
Press Releases
RAD Increases Ownership in Radiopharm Ventures to 87.5%
January 12, 2026
 · 
3 min read
Press Releases
Kazia Therapeutics to Participate in J.P. Morgan Healthcare Conference Week; Clinical and Translational Update Anticipated Before Month-End
January 9, 2026
 · 
5 min read
Press Releases
Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference
January 8, 2026
 · 
5 min read
Press Releases
Saluda Medical Receives Regulatory Approval for EVA™ Sensing Technology in Europe with recognition in Australia
January 8, 2026
 · 
4 min read
Press Releases
Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
January 8, 2026
 · 
7 min read
Press Releases
Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO
January 8, 2026
 · 
5 min read
Press Releases
Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S.-Based LumaBridge and Establishes New Oncology Center of Excellence
January 7, 2026
 · 
3 min read
Press Releases
Amplia Therapeutics to Present at 2026 ASCO Gastrointestinal Cancers Symposium
December 24, 2025
 · 
2 min read
Press Releases
Kazia Therapeutics Regains Full Nasdaq Listing Compliance
December 23, 2025
 · 
3 min read
Press Releases
Immutep Announces Positive Update on IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases, from Phase I Study
December 23, 2025
 · 
5 min read
Press Releases
Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal
December 23, 2025
 · 
4 min read
Press Releases
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
December 22, 2025
 · 
11 min read
Press Releases
Final, 247th participant randomized and commences treatment in Actinogen’s XanaMIA pivotal phase 2b/3 Alzheimer’s trial
December 19, 2025
 · 
8 min read
Press Releases
Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing Agreement for Ongoing ECLIPSE Clinical Development Program
December 17, 2025
 · 
9 min read
Press Releases
Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace
December 17, 2025
 · 
4 min read
Press Releases
Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution
December 16, 2025
 · 
3 min read
Press Releases
Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
December 15, 2025
 · 
5 min read
Press Releases
Patient Enrolment Completed in Phase 2 aGvHD Clinical Trial
December 15, 2025
 · 
4 min read
Press Releases
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial
December 12, 2025
 · 
4 min read
Load More